Effect of Catergen [(+)cyanidanol-3] on some haemostatic parameters in chronic liver diseases. 1984

G Pfliegler, and Z Boda, and L Dalmi, and G Weisz, and M Misz, and P Beck

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001780 Blood Coagulation Tests Laboratory tests for evaluating the individual's clotting mechanism. Coagulation Tests, Blood,Tests, Blood Coagulation,Blood Coagulation Test,Coagulation Test, Blood,Test, Blood Coagulation
D002392 Catechin An antioxidant flavonoid, occurring especially in woody plants as both (+)-catechin and (-)-epicatechin (cis) forms. Catechinic Acid,Catechuic Acid,(+)-Catechin,(+)-Cyanidanol,(+)-Cyanidanol-3,(-)-Epicatechin,(2R,3R)-2-(3,4-Dihydroxyphenyl)-3,5,7-chromanetriol,2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R-cis)-,3,3',4',5,7-Flavanpentol,Catergen,Cianidanol,Cyanidanol-3,Epicatechin,KB-53,Z 7300,Zyma,Cyanidanol 3,KB 53,KB53
D004796 Clinical Enzyme Tests Analyses for a specific enzyme activity, or of the level of a specific enzyme that is used to assess health and disease risk, for early detection of disease or disease prediction, diagnosis, and change in disease status. Enzyme Tests, Clinical,Clinical Enzyme Test,Enzyme Test, Clinical,Test, Clinical Enzyme,Tests, Clinical Enzyme
D005234 Fatty Liver Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS. Liver Steatosis,Steatohepatitis,Steatosis of Liver,Visceral Steatosis,Liver Steatoses,Liver, Fatty,Steatohepatitides,Steatoses, Liver,Steatoses, Visceral,Steatosis, Liver,Steatosis, Visceral,Visceral Steatoses
D005260 Female Females
D006487 Hemostasis The process which spontaneously arrests the flow of BLOOD from vessels carrying blood under pressure. It is accomplished by contraction of the vessels, adhesion and aggregation of formed blood elements (eg. ERYTHROCYTE AGGREGATION), and the process of BLOOD COAGULATION. Hemostases

Related Publications

G Pfliegler, and Z Boda, and L Dalmi, and G Weisz, and M Misz, and P Beck
January 1984, Acta physiologica Hungarica,
G Pfliegler, and Z Boda, and L Dalmi, and G Weisz, and M Misz, and P Beck
January 1983, Acta medica Hungarica,
G Pfliegler, and Z Boda, and L Dalmi, and G Weisz, and M Misz, and P Beck
November 1987, Schweizerische medizinische Wochenschrift,
G Pfliegler, and Z Boda, and L Dalmi, and G Weisz, and M Misz, and P Beck
January 1984, Acta physiologica Hungarica,
G Pfliegler, and Z Boda, and L Dalmi, and G Weisz, and M Misz, and P Beck
March 1980, Schweizerische medizinische Wochenschrift,
G Pfliegler, and Z Boda, and L Dalmi, and G Weisz, and M Misz, and P Beck
March 1990, Schweizerische medizinische Wochenschrift,
G Pfliegler, and Z Boda, and L Dalmi, and G Weisz, and M Misz, and P Beck
January 1986, Sovetskaia meditsina,
G Pfliegler, and Z Boda, and L Dalmi, and G Weisz, and M Misz, and P Beck
January 1984, Acta physiologica Hungarica,
G Pfliegler, and Z Boda, and L Dalmi, and G Weisz, and M Misz, and P Beck
August 1983, Thrombosis research,
G Pfliegler, and Z Boda, and L Dalmi, and G Weisz, and M Misz, and P Beck
November 1983, Wiener medizinische Wochenschrift (1946),
Copied contents to your clipboard!